20 hasil
Menampilkan 1–20 · 0,73 detik · RSS
The Lancet Haematology
Scopus
ISSN 2352-3026 · Elsevier BV · 20 artikel di indeks
-
Artikel Jurnal Teks lengkap
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
BACKGROUND: Previous global analyses, with known underdiagnosis and single cause per death attribution systems, provide only a small insight into the suspected high population health effect of sickle cell disease. Completed as part of the Global Burden of Diseases, Injuries, and Risk Factors Study…
-
Artikel Jurnal Teks lengkap
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
BACKGROUND: Anaemia is a major health problem worldwide. Global estimates of anaemia burden are crucial for developing appropriate interventions to meet current international targets for disease mitigation. We describe the prevalence, years lived with disability, and trends of anaemia and its…
-
Artikel Jurnal Teks lengkap
Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial
BACKGROUND: Time to treatment matters in traumatic haemorrhage but the optimal prehospital use of blood in major trauma remains uncertain. We investigated whether use of packed red blood cells (PRBC) and lyophilised plasma (LyoPlas) was superior to use of 0·9% sodium chloride for improving tissue…
-
Artikel Jurnal Teks lengkap
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
COVID-19 is associated with a high incidence of thrombotic complications, which can be explained by the complex and unique interplay between coronaviruses and endothelial cells, the local and systemic inflammatory response, and the coagulation system. Empirically, an intensified dose of thrombosis…
-
Artikel Jurnal Teks lengkap
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Background The emergence of highly active novel agents has led some to question the role of autologous haematopoietic stem-cell transplantation (HSCT) and subsequent consolidation therapy in newly diagnosed multiple myeloma. We therefore compared autologous HSCT with bortezomib–melphalan–prednisone…
-
Artikel Jurnal Teks lengkap
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
-
Artikel Jurnal Teks lengkap
Effects of the COVID-19 pandemic on supply and use of blood for transfusion
-
Artikel Jurnal Teks lengkap
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study